CN110477378B - Mouth-soluble instant drinking powder containing fat-soluble components and preparation method thereof - Google Patents
Mouth-soluble instant drinking powder containing fat-soluble components and preparation method thereof Download PDFInfo
- Publication number
- CN110477378B CN110477378B CN201910709728.4A CN201910709728A CN110477378B CN 110477378 B CN110477378 B CN 110477378B CN 201910709728 A CN201910709728 A CN 201910709728A CN 110477378 B CN110477378 B CN 110477378B
- Authority
- CN
- China
- Prior art keywords
- soluble
- mouth
- fat
- powder
- instant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims abstract description 62
- 230000035622 drinking Effects 0.000 title claims abstract description 58
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 43
- 239000002994 raw material Substances 0.000 claims abstract description 35
- 239000000203 mixture Substances 0.000 claims abstract description 25
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000004386 Erythritol Substances 0.000 claims abstract description 19
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940009714 erythritol Drugs 0.000 claims abstract description 19
- 235000019414 erythritol Nutrition 0.000 claims abstract description 19
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 19
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 16
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000811 xylitol Substances 0.000 claims abstract description 16
- 229960002675 xylitol Drugs 0.000 claims abstract description 16
- 235000010447 xylitol Nutrition 0.000 claims abstract description 16
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 16
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 11
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 11
- 239000004615 ingredient Substances 0.000 claims abstract description 9
- 238000012216 screening Methods 0.000 claims abstract description 5
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 16
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 14
- 235000012680 lutein Nutrition 0.000 claims description 9
- 239000001656 lutein Substances 0.000 claims description 9
- 229960005375 lutein Drugs 0.000 claims description 9
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 9
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 9
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 8
- 239000001168 astaxanthin Substances 0.000 claims description 8
- 235000013793 astaxanthin Nutrition 0.000 claims description 8
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 8
- 229940022405 astaxanthin Drugs 0.000 claims description 8
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 7
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 7
- 239000001751 lycopene Substances 0.000 claims description 7
- 235000012661 lycopene Nutrition 0.000 claims description 7
- 229960004999 lycopene Drugs 0.000 claims description 7
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 7
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 239000004322 Butylated hydroxytoluene Substances 0.000 claims description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 3
- 229940095259 butylated hydroxytoluene Drugs 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 235000019282 butylated hydroxyanisole Nutrition 0.000 claims description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 2
- 125000002635 lutein group Chemical group 0.000 claims description 2
- 235000010384 tocopherol Nutrition 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- 229960001295 tocopherol Drugs 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 2
- 239000004255 Butylated hydroxyanisole Substances 0.000 claims 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 44
- 239000004480 active ingredient Substances 0.000 abstract description 13
- 230000036541 health Effects 0.000 abstract description 6
- 239000000378 calcium silicate Substances 0.000 abstract description 5
- 229910052918 calcium silicate Inorganic materials 0.000 abstract description 5
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 abstract description 5
- 150000005846 sugar alcohols Chemical class 0.000 abstract description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 235000013376 functional food Nutrition 0.000 abstract description 2
- 230000009747 swallowing Effects 0.000 abstract description 2
- 239000012467 final product Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 description 24
- 238000011156 evaluation Methods 0.000 description 16
- 238000005469 granulation Methods 0.000 description 15
- 230000003179 granulation Effects 0.000 description 15
- 230000008569 process Effects 0.000 description 15
- 230000001953 sensory effect Effects 0.000 description 14
- 239000002245 particle Substances 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000005303 weighing Methods 0.000 description 9
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 8
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000001630 malic acid Substances 0.000 description 8
- 235000011090 malic acid Nutrition 0.000 description 8
- 239000005913 Maltodextrin Substances 0.000 description 6
- 229920002774 Maltodextrin Polymers 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 229940035034 maltodextrin Drugs 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 5
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 5
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 5
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 5
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 5
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 5
- 239000001775 zeaxanthin Substances 0.000 description 5
- 235000010930 zeaxanthin Nutrition 0.000 description 5
- 229940043269 zeaxanthin Drugs 0.000 description 5
- 239000013543 active substance Substances 0.000 description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 4
- 239000011648 beta-carotene Substances 0.000 description 4
- 235000013734 beta-carotene Nutrition 0.000 description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 4
- 229960002747 betacarotene Drugs 0.000 description 4
- 238000007908 dry granulation Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000000944 linseed oil Substances 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 4
- 235000005979 Citrus limon Nutrition 0.000 description 3
- 244000131522 Citrus pyriformis Species 0.000 description 3
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 3
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 3
- 206010056474 Erythrosis Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000005693 branched-chain amino acids Chemical class 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 235000021388 linseed oil Nutrition 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 229940078499 tricalcium phosphate Drugs 0.000 description 3
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 3
- 235000019731 tricalcium phosphate Nutrition 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000021551 crystal sugar Nutrition 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229940107604 lutein esters Drugs 0.000 description 2
- 150000002658 luteins Chemical class 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- QULIOZDJZXKLNY-UHFFFAOYSA-N 3,4,5-trihydroxy-2-propylbenzoic acid Chemical compound CCCC1=C(O)C(O)=C(O)C=C1C(O)=O QULIOZDJZXKLNY-UHFFFAOYSA-N 0.000 description 1
- FUWLWBDNQPTINE-UHFFFAOYSA-N 3-tert-butyl-1h-quinolin-2-one Chemical compound C1=CC=C2NC(=O)C(C(C)(C)C)=CC2=C1 FUWLWBDNQPTINE-UHFFFAOYSA-N 0.000 description 1
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000000579 abdominal fat Anatomy 0.000 description 1
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940108924 conjugated linoleic acid Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000001033 granulometry Methods 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The instant powder of mouth-soluble type containing fat soluble ingredient and its preparation method, said instant powder of mouth-soluble type is to contain fat soluble ingredient, instant raw materials and disperse raw material mixture of material to get final product through microencapsulation, wherein said instant raw materials are selected from xylitol, erythritol or their mixture; the dispersing material is selected from calcium silicate, silicon dioxide or a mixture thereof. The product of the invention is immediately melted after being drunk for 3s, and has fine and refreshing mouthfeel. Through the screening and combination of sugar alcohol direct drinking materials and dispersing materials, the problems that fat soluble active ingredients are difficult to absorb and swallowing is difficult are effectively solved. On one hand, the mouth-soluble instant drinking powder containing fat-soluble components can be directly provided for terminal customers, and can also be mixed with other nutrients for application in health care products and functional foods.
Description
Technical Field
The invention relates to a functional dietary supplement, in particular to a direct drinking preparation of fat-soluble active ingredients and a preparation method thereof.
Background
The fat-soluble carotenoid has stronger functions of oxidation resistance and the like, and the market demand is continuously increased. Wherein the lutein, zeaxanthin and lutein ester derived from flos Tagetis Erectae have unique eye protection function and can prevent ultraviolet injury. And simultaneously can be used as a strong oxidant to inhibit the activity of active oxygen free radicals, and has the effects of protecting skin and heart and enhancing immunity. No. 12 of the national ministry of health bulletin 2008, establishes approval of lutein ester as a functional new resource food. Meanwhile, zeaxanthin is also obtained in 2017 as a new resource food.
Astaxanthin which is found from natural sources at present has the strongest antioxidant capacity and has various physiological effects, such as unique effects of resisting oxidation, delaying senility, enhancing resistance, resisting tumors, preventing and treating senile dementia and cancers. Astaxanthin crosses the blood-brain barrier and thus protects the brain, the central nervous system and the eyes. Astaxanthin also has other effects: improving body endurance and reducing the risk of muscle damage; relieving asthenopia symptom, and improving visual sensitivity; reduction of wrinkles by internal supplementation; relieving the symptoms of hyperpigmentation (known as age spots); regulating cytokines, inhibiting gene expression of inflammatory cytokines and chemokines; improving stomach health, and relieving infection or inflammation caused by helicobacter pylori.
The functional oil is edible oil containing nutritional components capable of regulating human health. Camellia oil, walnut oil, linseed oil, perilla seed oil, DHA, and the like are considered the first choice of healthy oils because they can provide more unsaturated fatty acids. Medium Chain Triglyceride (MCT) and conjugated linoleic acid glyceride (CLA-TG) have remarkable effects on reducing body weight, abdominal fat area and waist circumference of human body, and thus are receiving more and more attention.
However, the poor solubility of various fat-soluble active ingredients in water limits the absorption of nutrient components. Some fat-soluble active substances have certain odors which are difficult to mask, such as fishy smell and the like, so that the active substances are difficult to eat. Therefore, the preparation of fat-soluble active ingredients is the key point for improving the mouthfeel and expanding the application of the fat-soluble active ingredients.
The fat-soluble active ingredient preparation is mainly in the form of soft capsule, solid beverage and tablet. Among which solid beverages are also most common. But people are more and more aware of the inconvenience of solid water taking, such as drinking water when taking water, which affects the milk amount of infants; the edible method is characterized in that after the edible product is infused with boiled water, the nutritional ingredients of the product are destroyed; meanwhile, the large amount of water is not beneficial to the taking and absorption of the old and the infant who have dysphagia. More and more people are noticing the disadvantages of the solid beverage formulation. Therefore, the solid product which can be instantly dissolved in the mouth, can be instantly melted in the mouth and does not need to be taken with water, and has fine and smooth mouthfeel is a new product form of the nutritional supplement pursued by people.
In recent years, people also pay attention to the point, and some products in the aspect of oral direct drinking are made. For example, CN 104687178A discloses a solid beverage for direct oral administration and a preparation method thereof, wherein 20-95 parts of sugar alcohol, DHA powder, shell powder and vitamin D powder are mixed and granulated to obtain the solid beverage, but the formulation with high sugar alcohol content has poor mouthfeel and may bring high health risk. CN 106259943A, CN 105105128A provide a kind of infant nutritional supplement formula suitable for weaning-away breast feeding and its preparation method. But the effect of improving the direct drinking property cannot be achieved by adding lecithin, in addition, the preparation process is complex, the prepared ultrafine powder is at risk of inhalation asphyxiation when being taken, especially for the old and infants with small salivary secretion, and the crystal sugar is used, so that the crystal sugar is not suitable for being taken too much by diabetics and infants.
In view of the above problems, the search for materials, formulations and preparation methods which can really achieve the direct drinking effect is a key factor for obtaining excellent direct drinking products.
Disclosure of Invention
The invention aims to provide a direct drinking product which can really achieve an excellent direct drinking effect.
Firstly, the invention provides a mouth-soluble instant drinking powder containing fat-soluble ingredients, which is prepared by microencapsulating a raw material mixture containing the fat-soluble ingredients, an instant drinking material and a dispersing material, wherein the instant drinking material is selected from xylitol, erythritol or a mixture thereof; the dispersing material is selected from calcium silicate, silicon dioxide or a mixture thereof.
Another object of the present invention is to provide a method for preparing the above-mentioned instant powder containing fat-soluble components, comprising the following steps:
(1) Uniformly mixing and sieving the raw material mixture to ensure that the mass ratio of the 60-120 meshes of material is not less than 90%;
(2) Granulating;
(3) Drying at 30-50 ℃;
(4) And (6) screening.
In the above description of the preparation method, the granulation can be performed by using granulation methods well known in the industry, such as wet granulation, dry granulation, swing granulation, extrusion granulation, fluidized bed granulation, spray granulation; the drying mode can be fluidized drying, oven drying and the like.
In the screening step, the particle size of the product is uniformly dispersed in 30-100 meshes according to requirements, and the proportion of particles passing through 80 meshes is less than 10%. The qualified product can be obtained after the product is sieved by a 30-mesh sieve through sieving, the particle size distribution of the qualified product is optimized by the process and the formula, the particle size distribution is uniform, no fine or coarse particles exist, the particle size distribution is approximately 1.
The mouth-soluble instant drinking powder containing fat-soluble components is prepared by processing a raw material mixture containing the fat-soluble active components, an instant drinking material and a dispersing material through an embedding process such as emulsification dispersion, spray drying and the like and a granulation process. The product has a mouth feel of 3s, and is fine and refreshing. Through the screening and combination of sugar alcohol direct drinking materials and dispersing materials, the problems that fat soluble active ingredients are difficult to absorb and swallowing is difficult are effectively solved. On the one hand, the invention provides the mouth-soluble instant drinking powder containing fat-soluble components, which can directly provide products for end customers and can also be mixed with other nutrients for application in health care products and functional foods.
Detailed Description
The invention provides a mouth-soluble instant drinking powder containing fat-soluble components, which is prepared by microencapsulating a raw material mixture containing the fat-soluble components, an instant drinking material and a dispersing material, wherein the instant drinking material is selected from xylitol, erythritol or a mixture thereof; the dispersing material is selected from calcium silicate, silicon dioxide or a mixture thereof.
In the technical scheme of the invention, the selection of the direct drinking material and/or the dispersing material is the key characteristic for determining the effect of the fat-soluble component-containing oral instant drinking powder. In the long-term search for suitable direct-drinking materials and formulation methods, we have found that the properties of the active ingredients have a very important influence on the choice of direct-drinking materials. By taking this factor into account in the development of products, it is possible to obtain really instant drinking particles with excellent effects. The research results to date found that: when the fat-soluble or non-fat-soluble active ingredients are prepared into the mouth-soluble instant drinking powder according to the technical framework of the invention, different combination requirements are provided for the compatible instant drinking material and/or dispersing material. On one hand, when the fat-soluble active ingredient is combined with a direct drinking material of xylitol/erythrose and a dispersed material of silicon dioxide/calcium silicate, the mouth-soluble direct drinking powder with excellent property characteristics can be obtained, but when the same direct drinking material and/or dispersed material is compatible with the representative non-fat-soluble active ingredient, the property and the quality of the obtained direct drinking powder product are unsatisfactory. The tests and results of examples 8, 9 and 10 as listed in the present specification. Thus, in a particular embodiment of the invention, the drink-through material is a mixture of xylitol and erythritol; preferably xylitol and erythritol in a mass ratio of 1; more preferably the mass ratio of xylitol to erythritol is 1. When the dispersion material is silicon dioxide, the dispersion material can obtain more excellent effect by matching with the active component and other materials.
On the other hand, the preparation process of the non-fat-soluble active ingredient is also explored, and the discovery shows that when some typical non-fat-soluble active ingredients are matched with erythrose (direct drinking material) and maltodextrin (dispersing material), direct drinking particle products with excellent quality can be obtained. Also, in comparative experiments, when erythrose and/or maltodextrin were used in combination with typical fat-soluble ingredients in an attempt, satisfactory products could not be obtained, and the results are shown in examples 5, 11, and 12.
In another embodiment of the present invention, the fat soluble ingredient is selected from lutein, lutein esters, zeaxanthin, astaxanthin, beta carotene, lycopene or mixtures thereof. Preferably lutein, lutein esters, zeaxanthin, beta-carotene, lycopene or mixtures thereof.
In another embodiment of the present invention, the raw material mixture comprises, by weight: 1 part of fat-soluble component, 0.5-3 parts of direct drinking material and 0.01-0.5 part of dispersing material. Preferably contains 1 part of fat-soluble component, 1-2 parts of direct drinking material and 0.01-0.2 part of dispersing material.
On the basis, the raw material mixture for preparing the oral instant drinking powder can also contain 0.01 to 0.1 weight part of flavoring agent. The correctant mainly comprises various essences and fruit powder substances, including citric acid, sodium citrate, malic acid, various essences and fruit powder. The addition was done according to the methods and amounts described in the prior art.
In still another aspect, the fat-soluble ingredients used to prepare the instant powder further comprise an antioxidant selected from tocopherol, ascorbic acid esters of fatty acids, butylated Hydroxytoluene (BHT), butylated Hydroxyanisole (BHA), propyl gallic acid, t-butylhydroxyquinoline, or mixtures thereof; the antioxidant accounts for 0.1-5% of the fat-soluble component by mass. Preferably 1 to 5%.
The present invention is further illustrated by the following non-limiting examples, which should not be construed as limiting the invention in any way, unless otherwise specified, and the fat-soluble active agents used in the present invention are commercially available. The active substances used in the examples of the present invention were purchased from Dalian Yi Nuo Bio Inc. Mainly comprises lutein ester, lutein, astaxanthin, lycopene, beta-carotene, zeaxanthin, linseed oil, perilla seed oil, DHA, CLA-TG and MCT.
The following methods were used in the present application to measure and evaluate the products, unless otherwise specified:
in the invention, the disintegration time limit is adopted to represent the dissolution efficiency of the direct drinking powder in the mouth, and the longer the disintegration time limit is, the poorer the direct drinking effect is. The method for measuring the disintegration time limit comprises the following steps: 500mL of the prepared phosphate buffer solution is placed in a beaker of a disintegration time-limit instrument, the instrument is installed, the water temperature is adjusted to 37 +/-0.5 ℃, and a 100-mesh screen is used as the bottom. The 1g sample was placed in a disintegration time-limit apparatus (Tianjin New Tianguang BJ-1 type), and the apparatus was started while counting time. And (5) finishing timing after the sample powder on the screen completely sinks and dissolves, and recording the disintegration time of the product. ( Preparation of phosphate buffer solution: 6.8g of potassium dihydrogen phosphate is weighed, dissolved in 500mL of water, adjusted to pH 6.8 with 0.1mol/mL sodium hydroxide solution and diluted to 1000mL with water. )
The product accelerated stability evaluation method provided by the invention is a method provided by Chinese pharmacopoeia: the measured changes in appearance, content, etc. of the product were made at 40 ℃ and 75% RH.
The sensory evaluation method comprises the following steps: randomly compiling sample numbers, requiring more than 10 evaluators to evaluate the appearance, smell, drinking property, gritty feeling, sweetness, acidity, taste (former taste) and taste (latter taste) of the samples in the same place by an evaluation group, dividing the total score by 9, scoring and summarizing to calculate an average value, namely a sensory evaluation value of each index of the product, and taking the sample with the highest score as an optimal sample.
The granulometry method described in the present invention is to use a American standard sieve to sieve and record the percentage of products passing 30 mesh, 80 mesh and 100 mesh.
Example 1
494g of xylitol, 494g of lutein ester, 2g of citric acid and 10g of strawberry fruit powder are weighed (the granularity of each raw material needs to be between 60 and 120 meshes). The raw materials are uniformly mixed, the lutein ester direct drinking powder is obtained by a wet granulation process, and the lutein ester direct drinking powder is fluidized and dried at 30 ℃. And (6) sieving. The yield thereof was found to be 45%. The 30, 60 and 80 mesh screen rates are 45%,10% and 2%, respectively. The disintegration time was 80s. The sensory evaluation score was 3 points, and the mouth was not quickly dissolved, had a strong gritty sensation, and was difficult to swallow.
Example 2
Weighing 300g of erythritol, 488g of lutein, DHA200g, 2g of malic acid and 10g of lemon fruit powder (the particle size of each raw material needs to be 60-120 meshes). The raw materials are uniformly mixed, and the lutein-DHA direct drinking powder is obtained through a dry granulation process. The yield thereof was found to be 55%. The screen mesh rates of 30 meshes, 60 meshes and 80 meshes are respectively 90%,50% and 40%. The disintegration time was 98s. The sensory evaluation of the powder is divided into 1 point, the powder is pasted with dry mouth, the mouth is flushed out after the mouth is opened, and the throat is stuck after the mouth is sucked.
Example 3
Weighing 375g of erythritol, 125g of xylitol, 500g of lycopene, 2g of sodium citrate and 10g of apple powder (the granularity of each raw material needs to be between 60 and 120 meshes). The raw materials are uniformly mixed, the lycopene direct drinking powder is obtained by a fluidized bed granulation process, and the lycopene direct drinking powder is dried by a 40-DEG oven. The yield thereof was found to be 75%. The 30, 60 and 80 mesh screen rates are respectively 90%,35% and 5%. The disintegration time was 25s. The sensory evaluation score of the sweet potato is 8 points, the taste is fine and smooth, the sweet potato is instantly melted in the mouth, and the sweet and sour degree is moderate. The product was agglomerated at 40 ℃ and 75% RH for 10 days.
Compared with the examples 1 and 2, the yield of the product obtained by mixing and using the xylitol and the erythritol in the implementation is greatly improved, the particle size distribution of the product is relatively uniform, the mouthfeel is fine and smooth, and the product is molten in the mouth.
Example 4
Weighing 241g of erythritol, 241g of xylitol, 482g of astaxanthin, 1g of malic acid, 30g of apple powder and 5g of silicon dioxide (the granularity of each raw material needs to be 60-120 meshes). The raw materials are uniformly mixed, and the astaxanthin direct drinking powder is obtained through a fluidized bed granulation process. The yield thereof was found to be 95%. The 30, 60 and 80 mesh screen rates are 95%,40% and 7% respectively. The disintegration time was 19s. The sensory evaluation score of the product is 8.2, the product has fine and smooth mouthfeel, is instantly melted in the mouth and has moderate sour and sweet degree. The product had no clumping at 40 ℃ and 75% RH for 6 months.
Compared with the embodiment 3, the xylitol and the erythritol are mixed and used in the embodiment to be matched with the silicon dioxide, so that the obtained product is improved in yield, more uniform in particle size distribution, fine and smooth in taste and instantly melted in the mouth. And simultaneously, the problem of caking of the product in the process of accelerating storage is solved.
Example 5
Weighing 333g of erythritol, 67g of xylitol, 200g of linseed oil, 319g of lutein ester, 1g of malic acid, 30g of apple powder and 50g of maltodextrin (the granularity of each raw material needs to be between 60 and 120 meshes). The raw materials are uniformly mixed, the lutein ester-linseed oil direct drinking powder is obtained through a fluidized bed granulation process, and the 50-DEG fluidized drying is carried out. The yield thereof was found to be 80%. The screen rates of 30 meshes, 60 meshes and 80 meshes are respectively 85%,40% and 9%. The disintegration time was 30s. The sensory evaluation score of the product is 7.2, the taste is fine and smooth, and the product can be dissolved in 5s after being eaten. The product agglomerated at 40 ℃ and 75% RH for 1 month.
Example 6
500g of sorbitol, 188g of beta-carotene, 100g of perilla seed oil, 2g of citric acid, 10g of blueberry powder and 200g of silicon dioxide (the granularity of each raw material needs to be between 60 and 120 meshes) are weighed. The raw materials are uniformly mixed, the beta carotene-perilla seed oil direct drinking powder is obtained by a swing granulation process, and the beta carotene-perilla seed oil direct drinking powder is fluidized and dried at 50 ℃. The yield thereof was found to be 58%. The screen mesh rates of 30 meshes, 60 meshes and 80 meshes are respectively 70%,50% and 10%. The disintegration time was 135s. The sensory evaluation score was 1 point, and the granules were insoluble in the mouth, remained a lot, and had a strong gritty feeling.
Example 7
Weighing 455g erythritol, 364g EGCG (epigallocatechin gallate), 1g malic acid, 30g apple powder and 150g maltodextrin, wherein the granularity of each raw material is 60-120 meshes. The raw materials are evenly mixed, and the EGCG direct drinking powder is obtained through a fluidized bed granulation process. The yield thereof was found to be 95%. The 30, 60 and 80 mesh screen rates are 95%,40% and 7% respectively. The disintegration time was 10s. The sensory evaluation score of the product is 8.5, the product has fine and smooth mouthfeel, instant melting in the mouth, no afterbitterness and moderate sour-sweet degree. The product had no clumping at 40 ℃ and 75% RH for 6 months.
Example 8
Weighing 150g of erythritol, 150g of xylitol, 469g of BCAA (branched chain amino acid), 1g of malic acid, 30g of apple powder and 200g of maltodextrin, wherein the granularity of each raw material is between 60 and 120 meshes. The raw materials are uniformly mixed, and the BCAA direct drinking powder is obtained through a fluidized bed granulation process. The yield thereof was found to be 55%. The screen mesh rates of 30 meshes, 60 meshes and 80 meshes are respectively 70%,40% and 7%. The disintegration time was 65s. The sensory evaluation score is 5 points, the dissolution time is longer in the mouth, and the sweet and sour degree is moderate.
Example 9
Weighing 300g of erythritol, 150g of xylitol, 2g of EGCG488g of sodium citrate, 10g of apple powder and 50g of silicon dioxide, wherein the granularity of each raw material is between 60 and 120 meshes. The raw materials are uniformly mixed, the EGCG direct drinking powder is obtained through a fluidized bed granulation process, and the EGCG direct drinking powder is dried in a 40-DEG oven. The yield thereof was found to be 75%. The screen mesh rates of 30 meshes, 60 meshes and 80 meshes are respectively 100%,80% and 60%. The disintegration time was 70s. The sensory evaluation score is 5.3, the powder is dry and difficult to swallow, the mouth cavity is flushed after the mouth is opened, the throat is stuck after the mouth is opened, the aftertaste is slightly bitter and astringent, the time for dissolving the powder in the mouth is 10s, and the sour and sweet degree is moderate. The product did not cake at 40 ℃ and 75% RH for 6 months.
Example 10
450g of erythritol, 488g of tricalcium phosphate, 2g of sodium citrate, 10g of apple powder and 5g of silicon dioxide are weighed, and the granularity of each raw material is between 60 and 120 meshes. The raw materials are uniformly mixed, tricalcium phosphate direct drinking powder is obtained through a fluidized bed granulation process, and the tricalcium phosphate direct drinking powder is dried in a 40-DEG oven. The yield thereof was found to be 85%. The 30, 60 and 80 mesh screen rates are respectively 90%,51% and 39%. The disintegration time was 16s. The sensory evaluation score is 4.3 points, the mouth feel is burnt and insoluble, the mouth is opened and then the mouth is flushed out of the cavity, the throat is stuck after the mouth is opened, the taste is slightly bitter, and the sour and sweet degree is moderate. The product agglomerated at 40 ℃ and 75% RH for 3 months.
Example 11
Weighing 300g of erythritol, 488g of lutein, DHA200g, 2g of malic acid, 10g of lemon fruit powder and 50g of calcium silicate (the granularity of each raw material needs to be between 60 and 120 meshes). The raw materials are uniformly mixed, and the lutein-DHA direct drinking powder is obtained through a dry granulation process. The yield thereof was found to be 55%. The screen mesh rates of 30 meshes, 60 meshes and 80 meshes are respectively 90%,50% and 40%. The disintegration time was 98s. The sensory evaluation of the powder is divided into 1 point, the powder is pasted with dry mouth, the mouth is flushed out after the mouth is opened, and the throat is stuck after the mouth is sucked. The product was agglomerated at 40 ℃ and 75% RH for 2 months.
Example 12
Weighing 300g of erythritol, 338g of lutein ester, DHA200g, 2g of malic acid, 10g of lemon fruit powder and 150g of maltodextrin, wherein the granularity of each raw material is between 60 and 120 meshes. The raw materials are uniformly mixed, and the lutein ester-DHA direct drinking powder is obtained through a dry granulation process. The yield thereof was found to be 53%. The screen mesh rates of 30 meshes, 60 meshes and 80 meshes are 65%,40% and 8% respectively. The disintegration time was 98s. The sensory evaluation score was 2 points, and the powder had a strong gritty feeling and was difficult to dissolve. The product was agglomerated at 40 ℃ and 75% RH for 15 days.
Claims (2)
1. The mouth-soluble instant drinking powder containing fat-soluble components is characterized in that:
the preparation raw materials comprise the following components in parts by weight: 1 part of fat-soluble component, 1-2 parts of direct drinking material and 0.01-0.2 part of dispersing material;
the fat-soluble component is selected from lutein, lutein ester, astaxanthin, lycopene or a mixture thereof;
the direct drinking material is a mixture of xylitol and erythritol according to the mass ratio of 1;
the dispersion material is silicon dioxide;
the preparation method of the mouth-soluble instant powder containing fat-soluble components comprises the following steps: (1) Uniformly mixing and sieving the raw material mixture to ensure that the mass ratio of the materials of 60 to 120 meshes is not less than 90%; (2) granulating; (3) drying at 30-50 ℃; and (4) screening.
2. A potpourri according to claim 1, wherein said fat soluble ingredients comprise antioxidants selected from the group consisting of tocopherol, butylated hydroxytoluene, butylated hydroxyanisole and mixtures thereof; the mass of the antioxidant is 0.1 to 5 percent of the fat-soluble component.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910709728.4A CN110477378B (en) | 2019-08-02 | 2019-08-02 | Mouth-soluble instant drinking powder containing fat-soluble components and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910709728.4A CN110477378B (en) | 2019-08-02 | 2019-08-02 | Mouth-soluble instant drinking powder containing fat-soluble components and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110477378A CN110477378A (en) | 2019-11-22 |
CN110477378B true CN110477378B (en) | 2022-11-29 |
Family
ID=68547832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910709728.4A Active CN110477378B (en) | 2019-08-02 | 2019-08-02 | Mouth-soluble instant drinking powder containing fat-soluble components and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110477378B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100226994A1 (en) * | 2007-10-03 | 2010-09-09 | Nobuaki Hirai | Granule, tablet and methods for producing the same |
US20100297031A1 (en) * | 2007-10-01 | 2010-11-25 | Laboratorios Lesvi, S.L. | Orodispersible tablets |
CN104687178A (en) * | 2015-03-13 | 2015-06-10 | 上海益力健营养品有限公司 | Solid beverage capable of being directly taken orally and preparation method thereof |
CN109170472A (en) * | 2018-10-16 | 2019-01-11 | 鲲鱼健康药业江苏有限公司 | Direct drinking type acerola concentrate solid beverage |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002037727A (en) * | 2000-07-26 | 2002-02-06 | Eisai Co Ltd | Lipid-soluble medicine-formulated rapid disintegrable solid pharmaceutical preparation and method for producing the same |
ES2546458T3 (en) * | 2005-10-21 | 2015-09-23 | Dsm Ip Assets B.V. | New formulations of fat-soluble active ingredients with high bioavailability |
-
2019
- 2019-08-02 CN CN201910709728.4A patent/CN110477378B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100297031A1 (en) * | 2007-10-01 | 2010-11-25 | Laboratorios Lesvi, S.L. | Orodispersible tablets |
US20100226994A1 (en) * | 2007-10-03 | 2010-09-09 | Nobuaki Hirai | Granule, tablet and methods for producing the same |
CN104687178A (en) * | 2015-03-13 | 2015-06-10 | 上海益力健营养品有限公司 | Solid beverage capable of being directly taken orally and preparation method thereof |
CN109170472A (en) * | 2018-10-16 | 2019-01-11 | 鲲鱼健康药业江苏有限公司 | Direct drinking type acerola concentrate solid beverage |
Also Published As
Publication number | Publication date |
---|---|
CN110477378A (en) | 2019-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7427572B2 (en) | nutritional composition | |
US2887436A (en) | Pharmaceutical compositions | |
KR101367741B1 (en) | Compositions comprising garcinia cambogia extract and methods for preparing the same | |
JP2005526854A (en) | Chewable composition containing psyllium gel-forming extract | |
CN104434865A (en) | Components and preparation of vitamin C effervescent tablets | |
CN104664370A (en) | Chewable flax tablet | |
CN109619566A (en) | A kind of nutraceutical for alleviating asthenopia | |
US20160089332A1 (en) | Gel-like composition having high ubiquinol content | |
EP0689834A2 (en) | Sustained release food or feed supplement containing vitamins and minerals | |
CN110477378B (en) | Mouth-soluble instant drinking powder containing fat-soluble components and preparation method thereof | |
CN110742257A (en) | Taste masking agent for astaxanthin-containing preparation and application thereof | |
KR101721145B1 (en) | - Food composition including -Carnitine Magnesium Citrate for diet and promoting bowel movement | |
CN106387596A (en) | Effervescent tablets capable of refreshing mind and restoring consciousness and preparation method of effervescent tablets | |
CN115444134A (en) | Blueberry lutein ester chewable tablet and preparation method thereof | |
CN109043279A (en) | Ginseng effervescent tablet and preparation method thereof | |
KR101610894B1 (en) | Taste-masked granules containing vitamin C | |
CN108853048A (en) | Organic selenium effervescent tablet and preparation method thereof | |
US20190343764A1 (en) | Excipient base formula, chewable formula containing the same, and the method of making chewable tablet | |
JP6849281B2 (en) | Composition containing liver hydrolyzate and Houttuynia cordata extract | |
CN1303904C (en) | Olive calcium tablet | |
JP2017193532A (en) | Composition for improving bone density, food composition for improving bone density, composition for improving liver function, and food composition for improving liver function | |
CN110477377A (en) | The molten type of the mouth of the ingredient containing non-fat-soluble directly drinks powder and preparation method thereof | |
JP2004194663A (en) | Functional food product | |
KR100446147B1 (en) | The manufacturing method and composition of the health support food utilized by simaroubaceae | |
CN115804759A (en) | A granule containing coenzyme Q10 and calcium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |